These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10657132)

  • 1. Epidermal growth factor receptor dimerization monitored in live cells.
    Blakely BT; Rossi FM; Tillotson B; Palmer M; Estelles A; Blau HM
    Nat Biotechnol; 2000 Feb; 18(2):218-22. PubMed ID: 10657132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of beta-galactosidase enzyme complementation technology as a high throughput screening format for antagonists of the epidermal growth factor receptor.
    Graham DL; Bevan N; Lowe PN; Palmer M; Rees S
    J Biomol Screen; 2001 Dec; 6(6):401-11. PubMed ID: 11788058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
    van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
    Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of dimerization and enzymatic activity of epidermal growth factor receptor in the absence of epidermal growth factor.
    Tanner KG
    Biochemistry; 1997 Dec; 36(48):14889-96. PubMed ID: 9398212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
    Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
    Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.
    Yu X; Sharma KD; Takahashi T; Iwamoto R; Mekada E
    Mol Biol Cell; 2002 Jul; 13(7):2547-57. PubMed ID: 12134089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
    Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
    Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.
    Stanley AM; Fleming KG
    J Mol Biol; 2005 Apr; 347(4):759-72. PubMed ID: 15769468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the InteraX system technology in a high-throughput screening environment.
    Büttner FH; Kumpf R; Menzel S; Reulle D; Valler MJ
    J Biomol Screen; 2005 Aug; 10(5):485-94. PubMed ID: 16093558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-phosphorylation of epidermal growth factor receptor is an intermolecular reaction.
    Sherrill JM
    Biochemistry; 1997 Oct; 36(42):12890-6. PubMed ID: 9335547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation.
    Kesarwala AH; Samrakandi MM; Piwnica-Worms D
    Cancer Res; 2009 Feb; 69(3):976-83. PubMed ID: 19176375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor induces changes of interaction between epidermal growth factor receptor and actin in intact cells.
    Song W; Xuan H; Lin Q
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):754-60. PubMed ID: 18685792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A betacellulin mutant promotes differentiation of pancreatic acinar AR42J cells into insulin-producing cells with low affinity of binding to ErbB1.
    Nagaoka T; Fukuda T; Hashizume T; Nishiyama T; Tada H; Yamada H; Salomon DS; Yamada S; Kojima I; Seno M
    J Mol Biol; 2008 Jun; 380(1):83-94. PubMed ID: 18508082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of GM1 enhances cell proliferation with epidermal growth factor without affecting the receptor localization in the microdomain in PC12 cells.
    Nishio M; Tajima O; Furukawa K; Urano T; Furukawa K
    Int J Oncol; 2005 Jan; 26(1):191-9. PubMed ID: 15586240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
    Ge G; Wu J; Wang Y; Lin Q
    Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a soluble human GH-receptor/EGF-receptor hybrid and its activation by GH.
    Hellgren G; Löfqvist C; Wikland KA; Carlsson B; Carlsson LM
    Cytokine; 2004 Mar; 25(6):260-4. PubMed ID: 15036241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo.
    Adams TE; Koziolek EJ; Hoyne PH; Bentley JD; Lu L; Lovrecz G; Ward CW; Lee FT; Scott AM; Nash AD; Rothacker J; Nice EC; Burgess AW; Johns TG
    Growth Factors; 2009 Jun; 27(3):141-54. PubMed ID: 19333814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
    Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
    Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.